BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37011647)

  • 21. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
    Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline SDHD mutation in familial phaeochromocytoma.
    Astuti D; Douglas F; Lennard TW; Aligianis IA; Woodward ER; Evans DG; Eng C; Latif F; Maher ER
    Lancet; 2001 Apr; 357(9263):1181-2. PubMed ID: 11323050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.
    Chatzikyriakou P; Touska P; Moonim MT; Obholzer R; Afridi S; Sandison A; Oakey RJ; Izatt L
    Cancer Genet; 2021 Aug; 256-257():110-114. PubMed ID: 34107390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
    Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
    Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?
    Lee SC; Chionh SB; Chong SM; Taschner PE
    Laryngoscope; 2003 Jun; 113(6):1055-8. PubMed ID: 12782822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma.
    Kim ES; Kim SY; Mo EY; Jang DK; Moon SD; Han JH
    Head Neck; 2014 Dec; 36(12):E131-5. PubMed ID: 24599702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.
    Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.
    Foley M; Sharma A; Garfield K; Maese L; Buchmann L; Boyle J; Kohlmann W; Jeter J; Greenberg S
    Fam Cancer; 2023 Apr; 22(2):217-224. PubMed ID: 36223042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.
    Dannenberg H; van Nederveen FH; Abbou M; Verhofstad AA; Komminoth P; de Krijger RR; Dinjens WN
    J Clin Oncol; 2005 Mar; 23(9):1894-901. PubMed ID: 15774781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel SDHD germ-line mutations in pheochromocytoma patients.
    Neumayer C; Moritz A; Asari R; Weinhäusel A; Hölzenbein T; Kretschmer G; Niederle B; Haas OA
    Eur J Clin Invest; 2007 Jul; 37(7):544-51. PubMed ID: 17576205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pressure rises: update on the genetics of phaeochromocytoma.
    Maher ER; Eng C
    Hum Mol Genet; 2002 Oct; 11(20):2347-54. PubMed ID: 12351569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
    Park YG; Park I; Kim Y; Lee HS; Lee W; Yoon S; Lee JL
    Clin Genitourin Cancer; 2024 Apr; 22(2):413-419. PubMed ID: 38228412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
    McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.